Abstract
The article by Ogirala and colleagues (Feb. 28 issue)1 concerning high-dose intramuscular triamcinolone in severe, chronic, life-threatening asthma prompts the following comments. First, in our view the patients were probably undertreated on entry into the study: the maintenance dose of prednisone was 10 mg daily or less in half the patients (Patients 2, 6, 7, 9, 10, and 12), which is a low dose for patients at risk for fatal asthma.2 Moreover, the maintenance dose of inhaled corticosteroids (triamcinolone acetonide) is not mentioned. Second, the dose of prednisone used in the study (15 mg daily) is not …
Original language | English (US) |
---|---|
Pages (from-to) | 429-431 |
Number of pages | 3 |
Journal | New England Journal of Medicine |
Volume | 325 |
Issue number | 6 |
DOIs | |
State | Published - Aug 8 1991 |
ASJC Scopus subject areas
- Medicine(all)